Cargando…
Construction of PR39 recombinant AAV under control of the HRE promoter and the effect of recombinant AAV on gene therapy of ischemic heart disease
The objective of this study was to investigate the effect of the PR39 recombinant adeno-associated virus (AAV) controlled by the hypoxia-responsive element (HRE) on gene therapy of ischemic heart disease. The minimal HRE was artificially synthesized and the AAV vector controlled by HRE was introduce...
Autores principales: | SUN, LIJUN, HAO, YUEWEN, NIE, XIAOWEI, ZHANG, XUEXIN, YANG, GUANGXIAO, WANG, QUANYING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493712/ https://www.ncbi.nlm.nih.gov/pubmed/23226731 http://dx.doi.org/10.3892/etm.2012.674 |
Ejemplares similares
-
Recombinant adeno-associated virus delivered human thioredoxin-PR39 prevents hypoxia-induced apoptosis of ECV304 cells☆
por: Ruan, Xiyun, et al.
Publicado: (2012) -
AAV Recombineering with Single Strand Oligonucleotides
por: Hirsch, Matthew L., et al.
Publicado: (2009) -
Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors
por: Zeltner, Nadja, et al.
Publicado: (2010) -
The Role of Recombinant AAV in Precise Genome Editing
por: Bijlani, Swati, et al.
Publicado: (2022) -
Adding recombinant AAVs to the cancer therapeutics mix
por: Mulcrone, Patrick L., et al.
Publicado: (2022)